2m 2m 2m 2m 2m 2m 2m
KYVERNA THERAP (KYTX)
NASDAQ
$7.30+$0.001 (+0.01%)
Price as of Aug 03, 2026 8:00 AM EDT- $443.8MMarket Cap
- 112.21%1-Year Change
- BiotechnologyIndustry
KYVERNA THERAP (KYTX)
$7.30+$0.001 (+0.01%)
KYTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.30 | ||
Change | -$0.19 (-2.54%) | ||
Open | $7.52 | ||
High | $7.61 | ||
Low | $7.13 | ||
Previous Close | $7.49 | ||
Volume | 526,072 | ||
30-Day Average Volume | 1,118,852 | ||
1-Week Change | -1.48% | ||
1-Month Change | -18.07% | ||
1-Year Change | 112.21% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 60.8M | ||
Total Assets | $257.0M | ||
Market Cap | $443.8M | ||
Enterprise Value | $461.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$39.7M | ||
Free Cash Flow | -$41.6M | ||
EBIT | -$39.1M | ||
EBITDA | -$38.8M | ||
Net Working Capital | $212.1M | ||
EPS | -$0.66 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -11 | ||
PEG | -1 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue